These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 20360660)
1. Liraglutide (Victoza) for type 2 diabetes. Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660 [TBL] [Abstract][Full Text] [Related]
2. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2]. Jahn E; Sausele T Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303 [TBL] [Abstract][Full Text] [Related]
3. Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes. Gross B J Pharm Pract; 2013 Apr; 26(2):144-50. PubMed ID: 23204146 [TBL] [Abstract][Full Text] [Related]
4. The development of non-peptide glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes. Moon HS; Kim MK; Son MH Arch Pharm Res; 2011 Jul; 34(7):1041-3. PubMed ID: 21811909 [TBL] [Abstract][Full Text] [Related]
5. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes. Ryan GJ; Hardy Y J Clin Pharm Ther; 2011 Jun; 36(3):260-74. PubMed ID: 21545609 [TBL] [Abstract][Full Text] [Related]
6. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus. Montanya E; Sesti G Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994 [TBL] [Abstract][Full Text] [Related]
10. Liraglutide in oral antidiabetic drug combination therapy. Garber AJ Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():13-9. PubMed ID: 22405265 [TBL] [Abstract][Full Text] [Related]
11. Liraglutide: clinical pharmacology and considerations for therapy. Sisson EM Pharmacotherapy; 2011 Sep; 31(9):896-911. PubMed ID: 21923591 [TBL] [Abstract][Full Text] [Related]
12. Review of the therapeutic uses of liraglutide. Ryan GJ; Foster KT; Jobe LJ Clin Ther; 2011 Jul; 33(7):793-811. PubMed ID: 21741090 [TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of type 2 diabetes and cardiovascular prevention: potentials for liraglutide]. Reboldi G G Ital Cardiol (Rome); 2009 Jul; 10(7):434-47. PubMed ID: 19761101 [TBL] [Abstract][Full Text] [Related]
14. Next-generation GLP-1 therapy: an introduction to liraglutide. Repas T Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107 [TBL] [Abstract][Full Text] [Related]
15. [Liraglutide (Victoza): human glucagon-like peptide-1 used in once daily injection for the treatment of type 2 diabetes]. Scheen AJ; Van Gaal LF Rev Med Liege; 2010; 65(7-8):464-70. PubMed ID: 20857706 [TBL] [Abstract][Full Text] [Related]
16. Treatment evaluation of liraglutide in type 2 diabetes. Kela R; Davies MJ Expert Opin Biol Ther; 2012 Nov; 12(11):1551-6. PubMed ID: 22897447 [TBL] [Abstract][Full Text] [Related]
17. Liraglutide: a review of its use in type 2 diabetes mellitus. Croom KF; McCormack PL Drugs; 2009 Oct; 69(14):1985-2004. PubMed ID: 19747013 [TBL] [Abstract][Full Text] [Related]
18. Liraglutide in type 2 diabetes mellitus. Baruah MP; Chaudhury T; Sethi BK; Dharmalingam M J Indian Med Assoc; 2012 May; 110(5):335-8. PubMed ID: 23360033 [TBL] [Abstract][Full Text] [Related]
19. An overview of the pharmacokinetics, efficacy and safety of liraglutide. Bode B Diabetes Res Clin Pract; 2012 Jul; 97(1):27-42. PubMed ID: 22245694 [TBL] [Abstract][Full Text] [Related]
20. Liraglutide: a review of the first once-daily GLP-1 receptor agonist. Bode B Am J Manag Care; 2011 Mar; 17(2 Suppl):S59-70. PubMed ID: 21517658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]